0000000000451351

AUTHOR

G. Militi

showing 1 related works from this author

1281P The prognostic impact of tissue tumour mutational burden (TMB) in the first-line treatment of advanced non-oncogene addicted non-small cell lun…

2020

Oncologymedicine.medical_specialtyOncogenebusiness.industrynon-small cell lung cancer (NSCLC)Hematologymedicine.diseaselaw.inventionFirst line treatmentOncologyRandomized controlled triallawInternal medicineMeta-analysismedicinebusinessAnnals of Oncology
researchProduct